Position history for MORGAN STANLEY's holdings in ROYALTY PHARMA PLC
MORGAN STANLEY holds 55.3M shares of RPRX (ROYALTY PHARMA PLC), worth $2.1B as of 2025-Q4. The position was increased (++25.2% shares). RPRX represents 0.1% of MORGAN STANLEY's portfolio.
Current Value
$2.1B
Current Shares
55.3M
Total Value Change
+$972M
Total Shares Change
+11.1M
Other major holders of RPRX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 55.3M |
+25.2% |
| $2.1B |
| 0.1% |
| $38.99 |
47 |
| 2025-Q3 | Decreased | 44.2M | -5.2% | $1.6B | 0.1% | $35.05 | 0 |
| 2025-Q2 | Increased | 46.6M | +13.6% | $1.7B | 0.1% | $35.46 | 43 |
| 2025-Q1 | Increased | 41M | +3.8% | $1.3B | 0.1% | $30.80 | 33 |
| 2024-Q4 | Decreased | 39.5M | -3.8% | $1B | 0.1% | $24.70 | 0 |
| 2024-Q3 | Decreased | 41.1M | -6.9% | $1.2B | 0.1% | $27.29 | 0 |
| 2024-Q2 | New | 44.1M | - | $1.2B | 0.1% | $25.32 | 44 |